Alwazzan, A. (2026) “Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction”, World Journal of Oncology, 17(5), pp. 676–682. doi:10.14740/wjon2800.